1. Home
  2. PDLB vs STRO Comparison

PDLB vs STRO Comparison

Compare PDLB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$17.44

Market Cap

405.9M

Sector

N/A

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$10.04

Market Cap

94.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
STRO
Founded
1960
2003
Country
United States
United States
Employees
218
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
405.9M
94.9M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
PDLB
STRO
Price
$17.44
$10.04
Analyst Decision
Hold
Analyst Count
0
7
Target Price
N/A
$19.67
AVG Volume (30 Days)
69.1K
110.9K
Earning Date
01-27-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
142.83
N/A
EPS
0.89
N/A
Revenue
$96,252,000.00
$105,646,000.00
Revenue This Year
$10.97
$62.61
Revenue Next Year
$8.59
N/A
P/E Ratio
$18.98
N/A
Revenue Growth
26.04
N/A
52 Week Low
$10.88
$5.23
52 Week High
$16.99
$24.80

Technical Indicators

Market Signals
Indicator
PDLB
STRO
Relative Strength Index (RSI) 74.68 88.67
Support Level $15.65 $7.88
Resistance Level $16.09 $10.10
Average True Range (ATR) 0.40 0.67
MACD 0.15 0.64
Stochastic Oscillator 83.76 98.99

Price Performance

Historical Comparison
PDLB
STRO

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: